Ectodysplasin A antibody (AA 101-200) (PE)
Quick Overview for Ectodysplasin A antibody (AA 101-200) (PE) (ABIN1712702)
Target
See all Ectodysplasin A (EDA) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 101-200
-
Cross-Reactivity
- Human, Mouse
-
Predicted Reactivity
- Rat,Cow
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human Ectodysplasin-A, membrane form/secreted form
-
Isotype
- IgG
-
-
-
-
Application Notes
- FCM 1:20-100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
-
Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20." in: Clinical and experimental immunology, Vol. 184, Issue 2, pp. 183-96, (2016) (PubMed).
: "
-
Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20." in: Clinical and experimental immunology, Vol. 184, Issue 2, pp. 183-96, (2016) (PubMed).
-
- Ectodysplasin A (EDA)
-
Alternative Name
- EDA/Ectodermal dysplasia protein
-
Background
-
Synonyms: ED1, HED, EDA1, EDA2, HED1, ODT1, XHED, ECTD1, XLHED, ED1-A1, ED1-A2, EDA-A1, EDA-A2, TNLG7C, STHAGX1, Ectodysplasin-A, Ectodermal dysplasia protein, EDA protein, EDA
Background: Seems to be involved in epithelial-mesenchymal signaling during morphogenesis of ectodermal organs. Isoform 1 binds only to the receptor EDAR, while isoform 3 binds exclusively to the receptor XEDAR.
-
Gene ID
- 1896
-
UniProt
- Q92838
-
Pathways
- Tube Formation
Target
-